Clinical trial EMERALD
Elacestrant Monotherapy for the Treatment of ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-Label, Active-Controlled, Multicenter Trial
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | Radius Health, Inc |
EudraCT Identifier | 2018-002990-24 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03778931 |
Inclusion criteria | ESR1-mut or ESR1-WT |
Last update |